EWING SARCOMA
Clinical trials for EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA trials appear
Sign up with your email to follow new studies for EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for kids with tough cancers
Disease control TerminatedThis study tested a combination of an immunotherapy drug (nivolumab) and low-dose chemotherapy in children and teenagers whose solid tumors had not responded to standard treatments. The goal was to see if the combination was safe and could help control the cancer. The trial was s…
Matched conditions: EWING SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Cancer drug combo studied in kids – but trial stopped early
Disease control TerminatedThis early-stage study tested a combination of two drugs (niraparib and dostarlimab) in children and teens aged 6 months to 18 years whose solid tumors had come back or did not respond to treatment. The main goals were to find safe doses and see how the drugs worked in the body. …
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC